Tony Chan |
Tony focuses his practice on mergers and acquisitions (M&A), including private equity and growth equity transactions, as well as corporate finance, emerging company formation and financing, public company governance, and general corporate matters. His clients include strategic buyers and sellers as well as financial sponsors and their portfolio companies in the life sciences, financial services, and technology sectors. He regularly advises on complex corporate transactions, and has experience in international and cross-border matters. Tony has been recognized for his life sciences and M&A work by a number of notable publications, including The Legal 500 US, Law360, IFLR1000, and Legal Media Group, with Law360 highlighting his work in navigating the complex life sciences industry and key partnership negotiations between biotechnology and drug companies. Tony currently serves as an adjunct professor at Georgetown Law School where he instructs on M&A law, and also maintains an active pro bono practice, serving as counsel to a number of nonprofit organizations. |
|
|